Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.3B | 4.8B | 4.1B | 4.5B |
Cost of revenue | 2.9B | 2.6B | 2.3B | 2.5B |
Gross profit | 2.4B | 2.1B | 1.8B | 2.0B |
Operating expense | ||||
Research & development | 36.5M | 130.3M | 46.8M | 50.7M |
Selling general and admin | 1.4B | -1.7B | 2.8B | -542.7M |
Other operating expenses | 43.6M | 84.9M | 15.3M | 46.5M |
Operating income | 951.8M | 378.0M | 563.8M | 834.3M |
Non operating interest income | ||||
Income | 86.9M | 26.8M | 49.3M | 29.3M |
Expense | 34.6M | 36.2M | 35.0M | 31.7M |
Other income expense | — | — | — | — |
Pretax income | 996.1M | 386.7M | 545.2M | 844.9M |
Tax provision | 155.2M | 90.0M | 76.5M | 192.4M |
Net income | 840.9M | 296.7M | 468.7M | 652.4M |
Basic EPS | 0.4 | — | — | — |
Diluted EPS | 0.4 | — | — | — |
Basic average shares | 1.4B | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 1.0B | 418.7M | 607.6M | 912.2M |
Net income from continuing op. | — | — | — | — |
Minority interests | -258.7M | -120.5M | -139.6M | -207.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |